Exchange: NASDAQ·Updated 12:57 PM EDT
QURE logo

QURE uniQure NV

$44.73
$1.50
(3.25%)
Today
EarningsNov 9
Mkt Cap$3.21B
Vol626,491.00

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
58

Bullish Sentiment

How do you feel about QURE?

Advertisement|Remove ads.